Clinical Trial Update: DFDBA and Xenograft (Cerabone)TM With Decortication in Intrabony Defects [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating DFDBA and Cerabone xenograft with decortication for periodontal intrabony defects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontal Intrabony Defects

Drugs mentioned

• Cerabone (bovine-derived hydroxyapatite xenograft)
• DFDBA (demineralized freeze-dried bone allograft)

Snippet

Sponsor: Krishnadevaraya College of Dental Sciences & Hospital | Conditions: Periodontal Intrabony Defects | Phase 4 | Status: COMPLETED